… , concluded that the incidence of ALI/ARDS in the USA was … While we know that ALI/ARDS
occurs less often in children … that exogenous surfactant therapy shows greater efficacy while in …

… suffice, hence our attempt at a targeted functional approach. … New techniques of surfactant
administration in combination … reported in the use of surfactant in ALI/ARDS, we agree with …

… on this, to create a consensus opinion about future research steps in this field. The … on
surfactant biology during ARDS and (2) randomized controlled trials comparing surfactant therapy …

… may have future therapeutic application in treatment of … contribute to loss of surfactant function
during the course of ARDS. … Surfactant treatment of patients with ALI/ARDS reduces lung …

… in COVID-19 ARDS, providing insights for future research. Methods: … surfactant therapy in
COVID-19 ARDS in our case series. … to patients with ALI/ARDS. One trial showed that synthetic …

… A total of 136 neonates with ALI/ARDS were enrolled, among … The neonates in the first two
groups were given PS at a dose of 70-… To arrive at the top five similar articles we use a word-…

… during a few days, which is often manifested as an acute lung injury/acute respiratory distress
syndrome (ALI/ARDS), … In the future, more basic experiments or clinical studies should be …

… surfactants is to diminish surface tension in the alveoli at the air–liquid interface and inhibit
its collapse at … current results for SP-D in ALI/ARDS from preclinical and clinical studies. Our …

… and highlights areas of future perspectives in therapeutics. … The cuboidal type II AECs
secrete a surfactant that is believed … a causal factor for development of ALI/ARDS [51]. However, …

… , and during this specific period exogenous surfactant treatment may be considered (11). …
Therefore, we decided to use budesonide combined with surfactant treatment to (i) minimize …